Business ❯Finance ❯Pharmaceuticals

Earnings Reports

AbbVie Bristol Myers Squibb Pfizer

Pfizer and Merck Diverge in Q2 Performance Amid Revised Forecasts

Pfizer achieves revenue growth and raises guidance, while Merck lowers profit outlook despite strong drug sales.

Bristol Myers Squibb Surges on Strong Q2 Performance and Raised Guidance